Androgen and Vitamin D Receptor Gene Polymorphisms: the Long and Short of Prostate Cancer Risk

This publication has 11 references indexed in Scilit:

• Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen Receptor
  JNCI Journal of the National Cancer Institute, 1997
• Vitamin D receptor genotypes in primary hyperparathyroidism
  Nature Medicine, 1995
• Suramin, hydrocortisone, and retinoic acid modify inhibitory effects of 1,25-dihydroxyvitamin D3 on prostatic epithelial cells
  Urologic Oncology: Seminars and Original Investigations, 1995
• Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)_n-expanded neuronopathies
  Human Molecular Genetics, 1995
• Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy)
  Journal of Clinical Endocrinology & Metabolism, 1995
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3
  Endocrinology, 1995
• Prediction of bone density from vitamin D receptor alleles
  Nature, 1994
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines
  Endocrinology, 1993
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation
  Cancer, 1992
• Cloning and expression of full-length cDNA encoding human vitamin D receptor.
  Proceedings of the National Academy of Sciences, 1988